Navigation Links
The Conference Forum Announces the Launch of Cell & Gene Therapy Day in NYC

The inaugural Cell & Gene Therapy Day takes place February 27, 2020 at the Crowne Plaza Times Square in New York City. The one-day event will be chaired by Dr Aiman Shalabi, VP R&D, Cell and Gene Therapies for GSK, with a diverse group of leaders in the space.

“We are witnessing significant innovation in cell and gene therapies, and we are at a turning point of advancing these technologies for solid tumors,” said Dr Shalabi. “This conference will engage global leaders on a series of scientific, investment landscape, regulatory and manufacturing topics with the ambition of accelerating these treatments to patients with solid cancers.”

Cell & Gene Therapy Day will focus primarily on the promising data and progress for solid tumors.
IO and cell therapy expert Dr Arie Belldegrun, Allogene, is the opening keynote and will kick off the day by addressing advancements in CAR-T cell therapy.

Immunotherapy expert, Dr Crystal Mackall, Director of the Stanford Center for Cancer Cell Therapy at Stanford University School of Medicine, will deliver a cornerstone presentation on new scientific frontiers in cell therapies for solid tumors. Dr Mackall has been a leader in treating hematologic tumors, with extensive work using CAR to target CD19 and CD22 in childhood leukemia.

The day will touch upon several different areas of cell and gene therapy. Dr Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration, will lead a panel on the evolution of regulatory policy for cell and gene therapy.

IO360 ° veteran Dr Ramy Ibrahim, Parker Institute for Cancer Immunotherapy, will address master protocols in cell and gene therapy, and his company’s own innovations in the field. Dr Ibrahim will also lead a discussion on the latest in collaborative development paradigms for cell therapies with Dr Elad Sharon, National Cancer Institute, and Dr Mitch Finer, ElevateBio.

Leaders from Loncor Investments, Cancer Research Institute, IQVIA and the Alliance for Regenerative Medicine will trace through the landscape and evolution of the cell and gene therapy marketplace.

One portion of the day will focus on pivotal developments in solid tumor treatment. The National Institutes of Health’s Dr Stephanie Goff will address tumor-infiltrating lymphocytes as a way of treating cancer. Dr Maria Fardis, Iovance, will speak on TILs as a way targeting individual tumor mutations. Dr Shalabi will return for an update on NY-ESO-1. Dr John Connolly, Tessa Therapeutics, will highlight the prognostic values of antiviral responses and using virus-specific T cells as a solid tumor immunotherapy platform. The day will conclude with debates on combinations with checkpoints, and bedside versus centralized manufacturing.

About Cell & Gene Therapy Day:
Cell & Gene Therapy Day convenes stakeholders spanning the science and business communities to report on the latest cell and gene therapy progress to fight a wider range of cancers beyond hematologic malignancies. Cell & Gene Therapy Day is available an independent one-day program with a luncheon and networking reception, or attendees can register for the three day IO360° program, which includes the Cell & Gene Therapy Day. For more information on IO360°, please click here.

About the Conference Forum:
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high-quality networking.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology news :

1. 2013 AAPS National Biotechnology Conference returns to San Diego
2. Oceanographer Sylvia Earle kicks off Northeasterns Sustaining Coastal Cities Conference
3. AAPS announces 2013 National Biotechnology Conference award winners
4. IAS 2013 conference program live online
5. Penn State to host pollinator health conference
6. NASP and ASCP Discuss Future of Specialty Pharmacy in Aging Market at Upcoming ASCP Conference
7. 21st European Biomass Conference and Exhibition
8. ENDO 2013 news conference and webcast schedule
9. IOF Worldwide Conference of Osteoporosis Patient Societies opens in Helsinki
10. Mount Sinai celebrates team science at second-annual SINAInnovations Conference Nov. 18-19, 2013
11. Albert Einstein College of Medicine hosts conference on Jewish genetic research
Post Your Comments:
(Date:12/4/2019)... Switzerland (PRWEB) , ... December 03, 2019 , ... ... biopharmaceutical R&D, today announced that Agenus , a clinical-stage immuno-oncology company developing ... of their antibody R&D workflow platform. Agenus will use the platform to support ...
(Date:12/2/2019)... , ... December 01, 2019 , ... ... and greatest tools, technologies, and techniques to hit the life-science landscape. For more ... innovative products speeding work in laboratories and facilitating biological discovery. This year’s crop ...
(Date:11/27/2019)... ... November 27, 2019 , ... The MyOnyx ... surface electromyography (sEMG) sensors that measure and display muscle activity in real time. ... being targeted for treatment. Both patient and therapist can see when exercises are ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... January 21, 2020 , ... QCDx , a private biotech company ... blood draw, today announced the sale of the proprietary RareScope™ instrument to the Carole ... used in clinical cancer research. , “The RareScope can detect and isolate intact and ...
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet ... achieve specific properties for use in harsh environments inside or outside of the ... to three metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, ...
(Date:1/7/2020)... ... January 06, 2020 , ... EconoFact, a non-profit media initiative ... at Tufts University, is pleased to announce that it was awarded a $50,000 ... Tufts University, and will help to expand the scope, exposure and distribution of ...
(Date:12/31/2019)... STATION, N.J. (PRWEB) , ... December 31, 2019 , ... ... throughput the conference that will be broadly focused on 3D cell culture , ... discuss its NASH 3D cell culture assays for assessing steatosis , inflammation and ...
Breaking Biology Technology: